Centessa Pharmaceuticals plc (CNTA) Tops Q3 EPS by 12c
Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q3 EPS of ($0.40), $0.12 better than the analyst estimate of ($0.52).
For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.
